Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marc Duey currently holds 256,155 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Duey has been a net buyer of APRE stock. They have purchased $25.1K and sold $0 worth of shares.
Marc Duey's most recent insider trade was on Dec 10, 2025, when they purchased 21,459 shares at $1.17 per share.
Marc Duey serves as Executive at Aprea Therapeutics, Inc. (APRE). They have executed 7 insider transactions totaling $25.1K over their tenure at the company.
Marc Duey holds the position of Executive at Aprea Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Marc Duey has shown a buying trading pattern, with $25.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Marc Duey was on Dec 10, 2025, when they purchased $25.1K worth of APRE shares. This transaction involved 21,459 shares at $1.17 per share.
Marc Duey currently owns 256,155 shares of Aprea Therapeutics, Inc. (APRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marc Duey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marc Duey has 7 Form 4 filings on record as an insider at Aprea Therapeutics, Inc..
Set alerts for Marc Duey and 40,000+ other insiders.